Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus tablets for oral suspension indicated for patients with tuberous ...

under its brand Sovaldi. On 11 March 2015, Natco Pharma announced that it is the first company in India to get approval for generic sofosbuvir tablets, 400mg, from Drugs Controller General (India).

NATCO Pharma Share Price: NATCO Pharma shares on Thursday crashed 20 per cent to hit the lower circuit after poor Q3 results FY2025. NATCO Pharma shared opened gap down with a cur of nearly 14 per ...